Year: 2018
Type: review
Abstract: Irritable bowel syndrome (IBS), one of the most frequent digestive disorders, is characterized by chronic and recurrent abdominal pain and altered bowel habit. The origin seems to be multifactorial and is still not well defined for the different subtypes. Genetic, epigenetic and sex-related modifications of the functioning of the nervous and immune-endocrine supersystems and regulation of brain-gut physiology and bile acid production and absorption are certainly involved. Acquired predisposition may act in conjunction with infectious, toxic, dietary and life event-related factors to enhance epithelial permeability and elicit mucosal microinflammation, immune activation and dysbiosis. Notably, strong evidence supports the role of bacterial, viral and parasitic infections in triggering IBS, and targeting microbiota seems promising in view of the positive response to microbiota-related therapies in some patients. However, the lack of highly predictive diagnostic biomarkers and the complexity and heterogeneity of IBS patients make management difficult and unsatisfactory in many cases, reducing patient health-related quality of life and increasing the sanitary burden. This article reviews specific alterations and interventions targeting the gut microbiota in IBS, including prebiotics, probiotics, synbiotics, non-absorbable antibiotics, diets, fecal transplantation and other potential future approaches useful for the diagnosis, prevention and treatment of IBS.
Source: Advances in Therapy
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Awards: G1296574178, G2506872838, G261937955, G3106911509, Desarrollo de un panel diagnóstico innovador para el Síndrome del Intestino irritable basado en la expresión sistémica diferencial de miRNAs, asociado a las manifestaciones clínicas y a la patología intestinal subyacente, Identificación de antígenos inductores de la respuesta humoral y de mecanismos de regulación de la inflamación intestinal en el síndrome del intestino irritable. Desarrollo de un panel diagnóstico diferencial., Identificación de perfiles bacterianos y epigenéticos género-dependientes en la fisiopatogenia del síndrome de intestino irritable
OpenAlex ID: W2790138328
